0001640455-21-000037.txt : 20210212
0001640455-21-000037.hdr.sgml : 20210212
20210212081017
ACCESSION NUMBER: 0001640455-21-000037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210210
FILED AS OF DATE: 20210212
DATE AS OF CHANGE: 20210212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Salter-Cid Luisa
CENTRAL INDEX KEY: 0001766404
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37998
FILM NUMBER: 21622920
MAIL ADDRESS:
STREET 1: C/O GOSSAMER BIO, INC.
STREET 2: 3013 SCIENCE PARK ROAD, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jounce Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640455
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 454870634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-3840
MAIL ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_161313540118759.xml
FORM 4
X0306
4
2021-02-10
0
0001640455
Jounce Therapeutics, Inc.
JNCE
0001766404
Salter-Cid Luisa
C/O GOSSAMER BIO, INC.
3013 SCIENCE PARK ROAD, SUITE 200
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (Right to Buy)
12.36
2021-02-10
4
A
0
31400
0
A
2031-02-10
Common Stock
31400.0
31400
D
The option was granted on February 10, 2021 and will vest in equal quarterly installments during the twelve quarters following the grant date, subject the to Reporting Person's continued service as a director.
/s/ Caroline Gammill, Attorney-in-fact
2021-02-12